trial · primary record
Nipocalimab
Thrombocytopenia, Neonatal Alloimmune
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 50 |
| Primary completion | 2029-12-11 |
| Primary endpoint | Fetus/Neonate with Outcome of Death or Adjudicated Severe Bleeding or Platelet Count Less Than (<) 30*10^9/L |
| Registry ID | NCT06533098 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:40.347Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06533098
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.